Literature DB >> 19385668

Engineered nanoscaled polyplex gene delivery systems.

Christian A Fernandez1, Kevin G Rice.   

Abstract

Improving the transfection efficiencies of nonviral gene delivery requires properly engineered nanoscaled delivery carriers that can overcome the multiple barriers associated with the delivery of oligonucleotides from the site of administration to the nucleus or cytoplasm of the target cell. This article reviews the current advantages and limitation of polyplex nonviral delivery systems, including the apparent barriers that limit gene expression efficiency compared to physical methods such as hydrodynamic dosing and electroporation. An emphasis is placed on engineered nanoscaled polyplexes (NSPs) of modular design that both self-assemble and systematically disassemble at the desired stage of delivery. It is suggested that NSPs of increasingly sophisticated designs are necessary to improve the efficiency of the rate limiting steps in gene delivery.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19385668     DOI: 10.1021/mp900033j

Source DB:  PubMed          Journal:  Mol Pharm        ISSN: 1543-8384            Impact factor:   4.939


  18 in total

1.  Polyplex-induced cytosolic nuclease activation leads to differential transgene expression.

Authors:  Rahul Rattan; Sriram Vaidyanathan; Gordon S-H Wu; Anisha Shakya; Bradford G Orr; Mark M Banaszak Holl
Journal:  Mol Pharm       Date:  2013-07-24       Impact factor: 4.939

2.  Ligands located within a cholesterol domain enhance gene delivery to the target tissue.

Authors:  Long Xu; Jamie Betker; Hao Yin; Thomas J Anchordoquy
Journal:  J Control Release       Date:  2012-03-09       Impact factor: 9.776

Review 3.  siRNA delivery to the lung: what's new?

Authors:  Olivia M Merkel; Israel Rubinstein; Thomas Kissel
Journal:  Adv Drug Deliv Rev       Date:  2014-06-05       Impact factor: 15.470

Review 4.  Drug delivery trends in clinical trials and translational medicine: challenges and opportunities in the delivery of nucleic acid-based therapeutics.

Authors:  Long Xu; Thomas Anchordoquy
Journal:  J Pharm Sci       Date:  2011-01       Impact factor: 3.534

5.  Effect of cholesterol nanodomains on the targeting of lipid-based gene delivery in cultured cells.

Authors:  Long Xu; Thomas J Anchordoquy
Journal:  Mol Pharm       Date:  2010-08-02       Impact factor: 4.939

Review 6.  Bioactive electrospun scaffolds delivering growth factors and genes for tissue engineering applications.

Authors:  Wei Ji; Yan Sun; Fang Yang; Jeroen J J P van den Beucken; Mingwen Fan; Zhi Chen; John A Jansen
Journal:  Pharm Res       Date:  2010-11-19       Impact factor: 4.200

7.  A Convergent Synthesis of Homogeneous Reducible Polypeptides.

Authors:  Mark D Ericson; Kevin G Rice
Journal:  Tetrahedron Lett       Date:  2013-08-28       Impact factor: 2.415

8.  Utilizing Inverse Emulsion Polymerization To Generate Responsive Nanogels for Cytosolic Protein Delivery.

Authors:  Kishore Raghupathi; Scott J Eron; Francesca Anson; Jeanne A Hardy; S Thayumanavan
Journal:  Mol Pharm       Date:  2017-11-02       Impact factor: 4.939

Review 9.  NTS-Polyplex: a potential nanocarrier for neurotrophic therapy of Parkinson's disease.

Authors:  Daniel Martinez-Fong; Michael J Bannon; Louis-Eric Trudeau; Juan A Gonzalez-Barrios; Martha L Arango-Rodriguez; Nancy G Hernandez-Chan; David Reyes-Corona; Juan Armendáriz-Borunda; Ivan Navarro-Quiroga
Journal:  Nanomedicine       Date:  2012-03-07       Impact factor: 5.307

10.  High-affinity PEGylated polyacridine peptide polyplexes mediate potent in vivo gene expression.

Authors:  K Kizzire; S Khargharia; K G Rice
Journal:  Gene Ther       Date:  2012-07-12       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.